Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Small-Cap · Madison

Madison Small Cap Fund Small Cap Fund Class R6 (MSCRX)

Ticker MSCRX · Since 2022-02-28 · · Holdings as of Jul 31, 2026

Expense ratio
0.92%$92/yr per $10k
1-yr return
−6.9%as of Dec 2025
Net assets
$154.9Mall share classes
Holdings
52

Bottom line

Is MSCRX a good fund? The bottom line

MSCRX is the Small Cap Fund Class R6 share class of Madison Small Cap Fund, a managed small-cap mutual fund from Madison.

It charges 0.92% — about $92 a year on every $10,000 invested, cheaper than 58% of small-cap funds we track.

It returned −6.9% over one year (as of Dec 31, 2025, per its prospectus).

With $155 million in net assets and 52 holdings, its largest position is State Street Global Advisors (5.5%) and the top 10 make up 34.4% of the portfolio.

What stands out

  • No front-end sales load

Updated Nov 19, 2026

What MSCRX invests in

"The Madison Small Cap Fund (the ""Fund"") seeks long-term capital appreciation."

"The Fund invests primarily in a diversified mix of common stocks of small cap U.S. companies that are believed to be undervalued by various measures and offer sound prospects for capital appreciation. For purposes of this Fund, small cap is defined as those companies with market capitalization of between $100 million and $15 billion. Under normal market conditions, the Fund will maintain at least 80% of its net assets (including borrowings for investment purposes) in small cap securities. The Fund's investment adviser, Madison Asset Management, LLC (""Madison""), focuses on core growth strategies through bottom-up fundamental research analysis to identify stocks of businesses that are selling at what it believes are substantial discounts to prices that accurately reflect their future earnings prospects. Madison conducts extensive research on each prospective investment using a five…

From the fund's prospectus (filed Feb 27, 2026).

MSCRX performance

Average annual total returns
1 yr5 yr10 yr
MSCRX−6.9%——
Small-Cap median+7.6%+7.0%+9.2%

Source: Fund prospectus, as of Dec 31, 2025

Full MSCRX performance history →

What MSCRX costs

On a $10,000 investment, MSCRX's 0.92% expense ratio costs about $92 a year. The prospectus estimates $1,131 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.

See the full MSCRX fee table →

MSCRX top 10 holdings

#Holding% of fund
1State Street Global Advisors5.53%
2Encompass Health Corp4.52%
3Scotts Miracle-Gro Co/The3.84%
4Knowles Corp3.33%
5HealthEquity Inc3.15%
6Workiva Inc3.01%
7Hayward Holdings Inc2.92%
8Core & Main Inc2.83%
9Carlisle Cos Inc2.72%
10Gitlab Inc2.55%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 34.4% of the fund. See all top 25 holdings and asset mix →

Alternatives to MSCRX

More funds like MSCRX →

MSCRX FAQ

What is the expense ratio of MSCRX?
MSCRX's expense ratio is 0.92%, which works out to about $92 a year for every $10,000 invested. The prospectus estimates total costs of $1,131 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is MSCRX a good investment?
It depends on your goals, but the data points to: no front-end sales load. This is general information, not personalized advice.
What does MSCRX hold?
MSCRX's largest holdings are State Street Global Advisors (5.5%), Encompass Health Corp (4.5%), Scotts Miracle-Gro Co/The (3.8%), Knowles Corp (3.3%), HealthEquity Inc (3.2%). It holds 52 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
Does MSCRX have a sales load?
No. MSCRX has no front-end sales charge.
Who manages MSCRX?
MSCRX is offered by Madison through Madison Funds.